Detailed price information for Hive Digital Technologies Ltd (HIVE-Q) from The Globe and Mail including charting and trades.
Detailed price information for Hive Digital Technologies Ltd (HIVE-Q) from The Globe and Mail including charting and trades.
Casale projected that HEPLISAV-B could reach at least 60% total market share in the U.S. by 2030, supported by expanding retail adoption and ongoing institutional demand.
Health and wellness products company Herbalife (NYSE:HLF) announced in Q3 CY2025, with sales up 2.7% year on year to $1.27 ...
Biohaven (BHVN) stock plunges as the FDA declines to approve its lead drug Vyglxia (troriluzole) targeted at spinocerebellar ...